Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Authors
Keywords
-
Journal
Biology-Basel
Volume 10, Issue 9, Pages 854
Publisher
MDPI AG
Online
2021-09-01
DOI
10.3390/biology10090854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer
- (2020) Xin-Yue Gu et al. Aging-US
- Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database
- (2020) M.E. Salem et al. ANNALS OF ONCOLOGY
- miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer
- (2020) Giovannina Barisciano et al. BRITISH JOURNAL OF CANCER
- MicroRNA‐375‐3p Enhances Chemosensitivity to 5‐Fluorouracil by Targeting Thymidylate Synthase in Colorectal Cancer
- (2020) Fei Xu et al. CANCER SCIENCE
- The Role of Probiotics in Colorectal Cancer Management
- (2020) Bhagavathi Sundaram Sivamaruthi et al. Evidence-based Complementary and Alternative Medicine
- Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling
- (2020) Chi-Hung R. Or et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long non‐coding RNA POU6F2‐AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR‐377/BRD4
- (2020) Guangru Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
- (2020) Federica Francescangeli et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers
- (2020) Rui Wei et al. Analytical Cellular Pathology
- DNA‑methylated gene markers for colorectal cancer in TCGA database
- (2020) Hui Zhang et al. Experimental and Therapeutic Medicine
- Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling
- (2020) Jessica Bauer et al. Scientific Reports
- DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
- (2020) Eva Galle et al. Clinical Epigenetics
- Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
- (2020) Gaofeng Liang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
- (2020) Aviad Ben-Shmuel et al. Frontiers in Immunology
- Correlation between FAK and EGF-Induced EMT in Colorectal Cancer Cells
- (2020) Kun Huang et al. Journal of Oncology
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
- (2020) Prashanthi Ramesh et al. APOPTOSIS
- Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes
- (2020) Kai Wang et al. BRITISH JOURNAL OF CANCER
- Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling
- (2020) Omar Al-Obeed et al. Cancer Cell International
- IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells
- (2020) Qiang Gao et al. CANCER LETTERS
- SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth
- (2020) Chunwan Lu et al. CANCER LETTERS
- Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis
- (2020) Mónica G. Mendoza-Rodríguez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53–MDM2 Interaction in Colorectal Cancer
- (2020) Ziyuan Wang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells
- (2020) Adrian Bogdan Țigu et al. MOLECULES
- S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer
- (2020) Yu-Hang Zhang et al. PHARMACOLOGICAL RESEARCH
- NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer
- (2020) Gertrud Knoll et al. Cell Death & Disease
- Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer
- (2020) Yujiao Zhang et al. Oncology Letters
- Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4
- (2020) Li-Hua Sun et al. Scientific Reports
- Interaction between Stem Cells and the Microenvironment for Musculoskeletal Repair
- (2020) Yong-Can Huang et al. Stem Cells International
- USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3
- (2020) Wei Zhan et al. Oncogenesis
- Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells
- (2020) Zhu-Lin Li et al. World Journal of Gastrointestinal Oncology
- β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest
- (2020) Ruonan Zhang et al. Frontiers in Bioengineering and Biotechnology
- Bavachinin mitigates DMH induced colon cancer in rats by altering p53/Bcl2/BAX signaling associated with apoptosis
- (2020) Chun Zhao et al. BIOTECHNIC & HISTOCHEMISTRY
- Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
- (2020) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression
- (2020) Yu-Hang Zhang et al. ONCOGENE
- Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins
- (2020) Yushan Yang et al. Cell Death & Disease
- Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation
- (2020) Vijesh Kumar Yadav et al. Cancers
- The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
- (2020) Plabon Kumar Das et al. Cells
- Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress
- (2020) Yi Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells
- (2019) Ichrak Riahi-Chebbi et al. Scientific Reports
- Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
- (2019) Raffaele Palmirotta et al. Frontiers in Oncology
- Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
- (2019) Zaira Rehman et al. PeerJ
- An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
- (2019) Ningning Li et al. Oncogenesis
- Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them
- (2019) M. A. F. Yahaya et al. Journal of Immunology Research
- FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression
- (2019) Vidhya Varghese et al. Scientific Reports
- Determination of thymidine phosphorylase expression level facilitates recurrence risk stratification in stage II/III colorectal cancer following adjuvant chemotherapy with oral fluoropyrimidines
- (2019) Naruji Kugimiya et al. Oncology Letters
- Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
- (2019) Rongsheng Zhang et al. Cell Death & Disease
- Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
- (2019) Zhuo Liu et al. OncoTargets and Therapy
- Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal
- (2019) Rana Yadak et al. Orphanet Journal of Rare Diseases
- (−)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway
- (2019) Xiaoqin La et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27
- (2019) Yong Yang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Downregulation of microRNA‑543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway
- (2019) Gang Liu et al. BIOSCIENCE REPORTS
- Combination therapies with HSP90 inhibitors against colorectal cancer
- (2019) Kushtrim Kryeziu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
- (2019) Patrycja Nowak-Sliwinska et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways
- (2019) Yuwei Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway
- (2019) Weilong Yao et al. Cancer Cell International
- Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure
- (2019) Maria Giovanna Francipane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
- (2019) Lin Mei et al. Journal of Hematology & Oncology
- A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant
- (2019) Vincenzo De Falco et al. MEDICINE
- Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer
- (2019) Joo Han Lee et al. MOLECULAR BIOLOGY REPORTS
- M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling
- (2019) Chen Wei et al. OncoTargets and Therapy
- Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy
- (2019) Hong Jiang et al. Oncology Letters
- Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX‑4 chemotherapy
- (2019) Song‑Hee Han et al. Oncology Letters
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
- (2019) Barbara Bassani et al. Cancers
- The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
- (2019) Zhenpeng Wang et al. Frontiers in Oncology
- DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
- (2019) Theodore J. Wigle et al. Pharmaceutics
- 5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter
- (2019) YUKIHIKO NISHIZAWA et al. ANTICANCER RESEARCH
- Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer
- (2019) Changlei Xi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic impact of methylenetetrahydrofolate reductase (MTHFR) polymorphism on the susceptibility to colorectal polyps: a meta-analysis
- (2019) Manyi Sun et al. BMC Medical Genetics
- RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
- (2019) Qingyuan Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
- (2019) Qian Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Noncoding RNAs in cancer therapy resistance and targeted drug development
- (2019) Wen-Tao Wang et al. Journal of Hematology & Oncology
- Synergistic Effect of Combined Treatment with Longan Flower Extract and 5-Fluorouracil on Colorectal Cancer Cells
- (2019) Szu-Jung Chen et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- BCL-2 family protein BOK is a positive regulator of uridine metabolism in mammals
- (2019) Rahul Srivastava et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Response prediction to oxaliplatin plus 5‑fluorouracil chemotherapy in patients with colorectal cancer using a four‑protein immunohistochemical model
- (2019) Junjie Gu et al. Oncology Letters
- Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil
- (2019) Tong Liu et al. NEOPLASIA
- CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
- (2019) Marcelo G. Kazanietz et al. Frontiers in Endocrinology
- Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes
- (2019) Guifang Guo et al. Journal for ImmunoTherapy of Cancer
- Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
- (2019) Qingmei Ye et al. Frontiers in Oncology
- TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
- (2019) Anastasios Ntavatzikos et al. World Journal of Gastrointestinal Oncology
- Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer
- (2019) Lisa Perilli et al. BMC CANCER
- miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells
- (2019) Junko Mukohyama et al. CANCER RESEARCH
- Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling
- (2019) Jiachi Ma et al. Cell Communication and Signaling
- Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer
- (2019) Ha Gyeong Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation
- (2019) Jianghong Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta‐analysis
- (2019) Xin‐Lin Chen et al. JOURNAL OF GENE MEDICINE
- Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
- (2019) Tongyan Liu et al. Journal of Hematology & Oncology
- BTK inhibitors synergize with 5‐FU to treat drug‐resistant TP53‐null colon cancers
- (2019) Marialuisa Lavitrano et al. JOURNAL OF PATHOLOGY
- Antiproliferative and apoptotic activities of 8-prenylnaringenin against human colon cancer cells
- (2019) Sanaz Koosha et al. LIFE SCIENCES
- Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
- (2019) Youn Young Park et al. MEDICINE
- GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism
- (2019) Sheng Zhang et al. MOLECULAR CANCER RESEARCH
- Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
- (2019) NaNa Keum et al. Nature Reviews Gastroenterology & Hepatology
- Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells
- (2019) Helena Moreira et al. Oxidative Medicine and Cellular Longevity
- CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer
- (2019) Nanzheng Chen et al. PLoS One
- MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling
- (2019) Chuncai Gu et al. Cell Death & Disease
- The microRNA‑200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2
- (2019) Jane Carter et al. Oncology Letters
- miR‑361 enhances sensitivity to 5‑fluorouracil by targeting the FOXM1‑ABCC5/10 signaling pathway in colorectal cancer
- (2019) Luyao Zhang et al. Oncology Letters
- Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2α and miR-494
- (2019) Yi Fang et al. Biomed Research International
- LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma
- (2019) Hui Zhang et al. Frontiers in Genetics
- Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
- (2019) Dan Wang et al. Journal for ImmunoTherapy of Cancer
- The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2019) Laura Moody et al. Cancers
- The Role of Tumor-Infiltrating B Cells in Tumor Immunity
- (2019) Fei Fei Guo et al. Journal of Oncology
- Origanum majorana Ethanolic Extract Promotes Colorectal Cancer Cell Death by Triggering Abortive Autophagy and Activation of the Extrinsic Apoptotic Pathway
- (2019) Nehla Benhalilou et al. Frontiers in Oncology
- Linking stemness with colorectal cancer initiation, progression, and therapy
- (2019) Deepak Narayanan Iyer et al. World Journal of Stem Cells
- RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC)
- (2019) Min-Li Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Autophagy: A novel mechanism of chemoresistance in cancers
- (2019) Xinyu Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Combined in silico and 19F NMR analysis of 5-fluorouracil metabolism in yeast at low ATP conditions
- (2019) Piotr H. Pawlowski et al. BIOSCIENCE REPORTS
- S-1 and oxaliplatin versus tegafur-uracil and leucovorin as postoperative adjuvant chemotherapy in patients with high-risk stage III colon cancer (ACTS-CC 02): a randomized, open-label, multicenter, phase 3, superiority trial
- (2019) E. Sunami et al. Clinical Colorectal Cancer
- Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
- (2019) Carin A. T. C. Lunenburg et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The genetic landscape of the human solute carrier (SLC) transporter superfamily
- (2019) Lena Schaller et al. HUMAN GENETICS
- A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy
- (2019) Mercedes Herrera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer
- (2019) Liye Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment
- (2019) Zohreh Jahanafrooz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New uracil analogs as downregulators of ABC transporters in 5-fluorouracil-resistant human leukemia HL-60 cell line
- (2019) Angelika Długosz-Pokorska et al. MOLECULAR BIOLOGY REPORTS
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Modified TLR‐mediated downregulation of miR‐125b‐5p enhances CD248 (endosialin)‐induced metastasis and drug resistance in colorectal cancer cells
- (2019) Ga‐Bin Park et al. MOLECULAR CARCINOGENESIS
- Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran
- (2019) Simoneide S. Titze-de-Almeida et al. Molecular Diagnosis & Therapy
- Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer
- (2019) Yang Xiong et al. Nanomedicine-Nanotechnology Biology and Medicine
- BH3 profiling discriminates the anti‑apoptotic status of 5‑fluorouracil‑resistant colon cancer cells
- (2019) Kazuma Ishikawa et al. ONCOLOGY REPORTS
- 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
- (2019) Sona Vodenkova et al. PHARMACOLOGY & THERAPEUTICS
- Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies
- (2019) Sumaira Javaid et al. PLoS One
- The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer
- (2019) Michela Pasello et al. SEMINARS IN CANCER BIOLOGY
- Oxymatrine reverses 5‑fluorouracil resistance by inhibition of colon cancer cell epithelial‑mesenchymal transition and NF‑κB signaling in�vitro
- (2019) Li Liang et al. Oncology Letters
- 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
- (2019) Sharon Christensen et al. Nature Communications
- Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells
- (2019) Zhuo Liu et al. Drug Design Development and Therapy
- CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
- (2019) Kenta Tsunekuni et al. Scientific Reports
- Clonal pattern dynamics in tumor: the concept of cancer stem cells
- (2019) Fabrizio Olmeda et al. Scientific Reports
- Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
- (2019) Jinbo Fu et al. Scientific Reports
- Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
- (2019) Waise Quarni et al. Scientific Reports
- Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer
- (2019) Kha Wai Hon et al. Scientific Reports
- MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription
- (2019) Tingting Liu et al. EBioMedicine
- Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers
- (2019) Shi-Jia Jin et al. Frontiers in Oncology
- Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies
- (2019) Audrey Vincent et al. World Journal of Stem Cells
- Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
- (2019) Vaishali Aggarwal et al. Biomolecules
- Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer
- (2019) Nicola Zizzo et al. Frontiers in Veterinary Science
- Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
- (2019) Shaoyan Lin et al. Cancer Communications
- Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells
- (2019) Shanwen Chen et al. CANCER LETTERS
- FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
- (2019) Chao Liu et al. CANCER LETTERS
- Regulation of ATP‐binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer
- (2019) Hao Wang et al. CANCER SCIENCE
- The Effect of Compound Sophora on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
- (2019) WeiHua Yin et al. Evidence-based Complementary and Alternative Medicine
- Green synthesis and biological evaluation of novel 5-fluorouracil derivatives as potent anticancer agents
- (2019) Farhat Jubeen et al. SAUDI PHARMACEUTICAL JOURNAL
- CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
- (2019) Guolin Zhang et al. Cancer Research and Treatment
- Molecular Insights into miRNA-Driven Resistance to 5-Fluorouracil and Oxaliplatin Chemotherapy: miR-23b Modulates the Epithelial–Mesenchymal Transition of Colorectal Cancer Cells
- (2019) Stasė Gasiulė et al. Journal of Clinical Medicine
- O-013Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer (mCRC): Preliminary results from the phase IIIb, international, open-label, early-access PRECONNECT study
- (2018) A Falcone et al. ANNALS OF ONCOLOGY
- Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer
- (2018) Changlei Xi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Schizandrin A enhances chemosensitivity of colon carcinoma cells to 5-fluorouracil through up-regulation of miR-195
- (2018) Dongfang Kong et al. BIOMEDICINE & PHARMACOTHERAPY
- Drug metabolizing enzymes and their inhibitors' role in cancer resistance
- (2018) Shelly Pathania et al. BIOMEDICINE & PHARMACOTHERAPY
- Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer
- (2018) Hanqing Hu et al. BIOSCIENCE REPORTS
- ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
- (2018) Z. Kozovska et al. BMC CANCER
- Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway
- (2018) Haizhou Liu et al. Cell Communication and Signaling
- The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression
- (2018) Xiaoming Zhong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells
- (2018) Shu Gong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine
- (2018) Xinqiang Hong et al. Chinese Journal of Cancer Research
- Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?
- (2018) Marco Tampellini et al. Future Oncology
- Autophagy facilitates anticancer effect of 5-fluorouracil in HCT-116 cells
- (2018) Tong Liu et al. Journal of Cancer Research and Therapeutics
- Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the β-catenin pathway through miR-200c
- (2018) Fatemeh Karimi Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- DNA methylation-mediated repression of miR-181a/135a/302c expression promotes the microsatellite-unstable colorectal cancer development and 5-FU resistance via targeting PLAG1
- (2018) Lu Shi et al. Journal of Genetics and Genomics
- Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells
- (2018) Heng Fan et al. Molecular Medicine Reports
- Heat shock protein 27 knockdown using nucleotide‑based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells
- (2018) Takehiro Shimada et al. ONCOLOGY REPORTS
- Thymidine phosphorylase: A potential new target for treating cardiovascular disease
- (2018) Wei Li et al. TRENDS IN CARDIOVASCULAR MEDICINE
- miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
- (2018) Xiaomin Meng et al. OncoTargets and Therapy
- Bufalin and 5‑fluorouracil synergistically induce apoptosis in colorectal cancer cells
- (2018) Xiao‑Yu Dai et al. Oncology Letters
- Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells
- (2018) Eun-Ji Kim et al. Oncotarget
- Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells
- (2018) Shaojia Wen et al. Artificial Cells Nanomedicine and Biotechnology
- DNA Damage, Repair, and Cancer Metabolism
- (2018) Marc-Olivier Turgeon et al. Frontiers in Oncology
- Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway
- (2018) Wenyue Liu et al. CANCER SCIENCE
- The potential of exosomes derived from colorectal cancer as a biomarker
- (2018) Yang Xiao et al. CLINICA CHIMICA ACTA
- LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells
- (2018) Tonghuai Li et al. MEDICINE
- Histone deacetylase inhibitors sensitize 5‑fluorouracil‑resistant MDA‑MB‑468 breast cancer cells to 5‑fluorouracil
- (2018) Tetsuya Minegaki et al. Oncology Letters
- ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer
- (2018) Zhen Zhang et al. BIOSCIENCE REPORTS
- The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
- (2018) Ryutaro Mori et al. Gastric Cancer
- Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer
- (2018) Anjing Ren et al. INTERNATIONAL JOURNAL OF CANCER
- The Roles of Autophagy in Cancer
- (2018) Chul Yun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
- (2018) Elena Andreucci et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
- (2018) Wei Xiao et al. MOLECULAR CANCER RESEARCH
- MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5‑fluorouracil in MEK1 Q56P‑mutant colorectal cancer cells
- (2018) Changwen Jing et al. Molecular Medicine Reports
- Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance
- (2018) Y.-B. Hu et al. ONCOGENE
- Therapy resistance mediated by cancer stem cells
- (2018) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy
- (2018) Meng Wang et al. Cell Death & Disease
- Effect of fibroblast co‑culture on the proliferation, viability and drug response of colon cancer cells
- (2018) Byumseok Koh et al. Oncology Letters
- Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients
- (2018) Mariam A. Fouad et al. Frontiers in Pharmacology
- The Dynamic Roles of Mesenchymal Stem Cells in Colon Cancer
- (2018) Shan Wang et al. Canadian Journal of Gastroenterology and Hepatology
- Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1)
- (2018) Massimiliano Filosto et al. Journal of Clinical Medicine
- Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2
- (2018) Arnatchai Maiuthed et al. Cancers
- Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
- (2018) Xiaofei Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Schedule-dependent synergistic effects of 5-fluorouracil and selumetinib in KRAS or BRAF mutant colon cancer models
- (2018) Hye Yeon Jang et al. BIOCHEMICAL PHARMACOLOGY
- WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy
- (2017) Guozhong Jiang et al. Genetic Testing and Molecular Biomarkers
- Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance
- (2017) Anke Nijhuis et al. HUMAN MOLECULAR GENETICS
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
- (2017) Manuela Terranova-Barberio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice
- (2017) Pan Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulated Polarization of Tumor-Associated Macrophages by miR-145 via Colorectal Cancer–Derived Extracellular Vesicles
- (2017) Haruka Shinohara et al. JOURNAL OF IMMUNOLOGY
- MACC1 facilitates chemoresistance and cancer stem cell-like properties of colon cancer cells through the PI3K/AKT signaling pathway
- (2017) Jiankai Wang et al. Molecular Medicine Reports
- The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3
- (2017) T.J. Miller et al. PATHOLOGY
- Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells
- (2017) Y Shen et al. PHARMACOGENOMICS JOURNAL
- Apoptosis mediated chemosensitization of tumor cells to 5-fluorouracil on supplementation of fish oil in experimental colon carcinoma
- (2017) Isha Rani et al. TUMOR BIOLOGY
- BCL-XL overexpression promotes tumor progression-associated properties
- (2017) Daniela Trisciuoglio et al. Cell Death & Disease
- Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer
- (2017) Ka-Rham Kim et al. Oncology Letters
- Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasis
- (2017) Daiki Kikuchi et al. Oncology Letters
- NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations
- (2017) Satya Narayan et al. Oncotarget
- Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression
- (2017) Yang Xiao et al. Oncotarget
- Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation
- (2017) Jianming He et al. Journal of Cancer
- Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients
- (2017) Pavel Dvorak et al. Journal of Cancer
- HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
- (2017) Lei Sun et al. Journal of Cancer
- Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
- (2017) Rashidah Baharudin et al. Frontiers in Pharmacology
- Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p
- (2017) Zehua Bian et al. Oncogenesis
- Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
- (2017) Alberto Malesci et al. OncoImmunology
- Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
- (2017) Trung Vu et al. Cancers
- CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer
- (2017) Xinfeng Yu et al. Scientific Reports
- miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis
- (2017) Ci Zhao et al. Scientific Reports
- The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey
- (2016) J. D. Young BIOCHEMICAL SOCIETY TRANSACTIONS
- Sensitization of 5-Fluorouracil-Resistant SNUC5 Colon Cancer Cells to Apoptosis by α-Mangostin
- (2016) June Lee et al. Biomolecules & Therapeutics
- Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210
- (2016) Elisabetta Bigagli et al. CANCER BIOLOGY & THERAPY
- Suppression of TWIST1 enhances the sensitivity of colon cancer cells to 5-fluorouracil
- (2016) Monika Sakowicz-Burkiewicz et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Twist mediates an aggressive phenotype in human colorectal cancer cells
- (2016) JUN-JIAN DENG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM–CHK2–P53 pathway
- (2016) Jing Yao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Effect of 5-fluorouracil on membranous PD-L1 expression in colon cancer cells.
- (2016) Gaurav Goel et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells
- (2016) JaeJin An et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells
- (2016) Kouji Okada et al. ONCOLOGY REPORTS
- Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells
- (2016) Yuan Li et al. TUMOR BIOLOGY
- Bcl-xL is an oncogenic driver in colorectal cancer
- (2016) Anna-Lena Scherr et al. Cell Death & Disease
- Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
- (2016) Samuel Gonçalves-Ribeiro et al. Oncotarget
- CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype
- (2016) Amy V. Paschall et al. Oncotarget
- The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
- (2016) Gabriele Romano et al. Oncotarget
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
- (2016) Wanyin Chen et al. Stem Cells International
- MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2
- (2016) Haijun Wu et al. Biology Open
- 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
- (2016) Lauren Van Der Kraak et al. Journal for ImmunoTherapy of Cancer
- Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
- (2016) Andrea Botticelli et al. PLoS One
- Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2′-Deoxyuridine in Colorectal Cancer Cell Lines
- (2016) Hiroshi Tsukihara et al. PLoS One
- The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells
- (2016) Wen-Shih Huang et al. PLoS One
- MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells
- (2015) Honghe Zhang et al. CANCER LETTERS
- Homeostatic responses of colonic LGR5+stem cells following acutein vivoexposure to a genotoxic carcinogen
- (2015) Eunjoo Kim et al. CARCINOGENESIS
- H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance
- (2015) Amy V. Paschall et al. JOURNAL OF IMMUNOLOGY
- Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
- (2015) Didier Meulendijks et al. LANCET ONCOLOGY
- MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
- (2015) Y Zhang et al. Cell Death & Disease
- Cancer stem cells in progression of colorectal cancer
- (2015) Yujuan Zhou et al. Oncotarget
- 5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair
- (2015) Upadhyayula Sai Srinivas et al. Oncotarget
- Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma
- (2015) Dae-Woon Eom et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- Dynamic Modulation of Thymidylate Synthase Gene Expression and Fluorouracil Sensitivity in Human Colorectal Cancer Cells
- (2015) Kentaro Wakasa et al. PLoS One
- Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer
- (2015) Yibing Hu et al. PLoS One
- 5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53-mutated colon cancer cells
- (2014) TOMOFUMI AKASAKA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
- (2014) Suqin He et al. INVESTIGATIONAL NEW DRUGS
- CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
- (2014) Zhenyu Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The BRCA2 gene is a potential molecular target during 5-fluorouracil therapy in human oral cancer cells
- (2014) YOSUKE NAKAGAWA et al. ONCOLOGY REPORTS
- FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy
- (2014) Beatrice Mohelnikova-Duchonova WORLD JOURNAL OF GASTROENTEROLOGY
- Recent studies of 5-fluorouracil resistance in pancreatic cancer
- (2014) Wei-Bin Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Evaluation of 5-Fluorouracil Metabolic Enzymes as Predictors of Response to Adjuvant Chemotherapy Outcomes in Patients with Stage II/III Colorectal Cancer: A Decision-Curve Analysis
- (2014) Kohei Shigeta et al. WORLD JOURNAL OF SURGERY
- Thymidine phosphorylase mRNA expression may be a predictor of response to post-operative adjuvant chemotherapy with S-1 in patients with stage III colorectal cancer
- (2014) MASAICHI OGAWA et al. Oncology Letters
- The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil
- (2013) Long-Hao Li et al. EUROPEAN JOURNAL OF CANCER
- Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy
- (2012) Lee Cheng Phua et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix
- (2012) Kiyoshi Hasegawa et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Thymidylate synthase and thymidine phosphorylase mRNA expression in primary lesions using laser capture microdissection is useful for prediction of the efficacy of FOLFOX treatment in colorectal cancer patients with liver metastasis
- (2012) KENSUKE KUMAMOTO et al. Oncology Letters
- Epigenetic Modifications
- (2011) Diane E. Handy et al. CIRCULATION
- Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward?
- (2010) Shayna L. Showalter et al. CANCER BIOLOGY & THERAPY
- Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study
- (2010) Arantza Fariña-Sarasqueta et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started